Vitamin E TPGS based transferosomes augmented TAT as a promising delivery system for improved transdermal delivery of raloxifene

Raloxifene is commonly used for breast cancer protection. The low bioavailability of raloxifene (2%) is the result of its low solubility and intestinal glucuronidation. The nano-lipid carriers are characterized by small particle size, biocompatibility, and sustainable properties that improve cellula...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhakamy, Nabil A., Fahmy, Usama A., Ahmed, Osama A. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934291/
https://www.ncbi.nlm.nih.gov/pubmed/31881053
http://dx.doi.org/10.1371/journal.pone.0226639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934291/
https://www.ncbi.nlm.nih.gov/pubmed/31881053
http://dx.doi.org/10.1371/journal.pone.0226639

Ejemplares similares